Replies to post #300462 on NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

I agree...but I just hope we are not moving too fast with the vaccines and putting people at risk for yet to be determine complications.

I think we need a vaccine else we wait out the storm for another year or so.

I am pulling for the Cambridge crowd with the monkey cough virus vaccine. I think that is most likely amongst the candidates floating around for a vaccine [very skeptical of Moderna]

We do not need it to get out to everybody. Once we have a vaccine we de-risk the future and can get back to normal. Still masks and distancing for a bit, but no fear of lockdowns

[kfa670]

Agreed Ex

[Hopeforthefuture3]

Ex I also think we need a vaccine but I like the phase 1 data from nvax. If I read it correctly mrna had fair amount of side effects. Just hope someone comes out with a safe and effective one.
Just some anecdotal data on covid. A co-worker his wife and daughter all had covid. The wife he took to a large nearby (2 hours away) city hospital and she spent 10 days on a ventilator. The husband (15 years older) spent his 14 days of quarantine putting a new roof on his house - said he had a sniffle. The daughter felt ill but nothing severe. Crazy how different the impacts can be.

[longfellow95]

Cambridge vaccine didn't work with the macaques. No reason why it should work in humans.
Your Govt has now thrown another $1.6B at a different candidate; namely Novavax.

The company had its IPO on Dec. 11, 1995. It opened at a (split-adjusted) price of $85 a share. Almost six years later, on Oct. 3, 2001, the stock hit its all-time high, at a (split-adjusted) price of $300 a share. Now the stock sits at just $4.31 a share. Imagine the unhappy investor out there who's sitting on losses of almost 99%. Novavax has caused a lot of financial agony to plenty of people.
This year, the stock has dropped all the way down to a micro-cap, valued at $106 million by the market. Earlier this year, Novavax had to do a 20-for-1 reverse split in order to keep its shares trading on the Nasdaq. More than 20% of its float is sold short.

https://www.fool.com/investing/2019/11/02/could-novavax-be-a-millionaire-maker-stock.aspx
That was last year. Some parallels with NWBO...

What a difference a year can make.
Now they have friends and backers in all the right places..
Gates, BARDA, CEPI. Novavax execs have been on BARDA, who run Operation Warp Speed.

https://www.nytimes.com/2020/07/16/health/coronavirus-vaccine-novavax.html

https://www.precisionvaccinations.com/vaccines/nvx-cov2373-sars-cov-2-vaccine